Fennec Pharmaceuticals Statistics

Total Valuation

TSX:FRX has a market cap or net worth of CAD 361.28 million. The enterprise value is 357.68 million.

Market Cap	361.28M
Enterprise Value	357.68M

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	32.78M
Shares Outstanding	n/a
Shares Change (YoY)	+1.25%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	23.28%
Float	17.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.32
PS Ratio	6.69
PB Ratio	-57.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-37.01
EV / Sales	6.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.69

Current Ratio	4.69
Quick Ratio	4.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.39%
Return on Invested Capital (ROIC)	-13.94%
Return on Capital Employed (ROCE)	-11.82%
Revenue Per Employee	1.69M
Profits Per Employee	-302,040
Employee Count	32
Asset Turnover	0.72
Inventory Turnover	1.48

Taxes

In the past 12 months, TSX:FRX has paid 508,405 in taxes.

Income Tax	508,405
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.60% in the last 52 weeks. The beta is 0.75, so TSX:FRX's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+84.60%
50-Day Moving Average	12.14
200-Day Moving Average	10.66
Relative Strength Index (RSI)	40.72
Average Volume (20 Days)	1,704

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.29

Income Statement

In the last 12 months, TSX:FRX had revenue of CAD 54.03 million and -9.67 million in losses. Loss per share was -0.36.

Revenue	54.03M
Gross Profit	50.31M
Operating Income	-6.49M
Pretax Income	-9.16M
Net Income	-9.67M
EBITDA	-6.03M
EBIT	-6.49M
Loss Per Share	-0.36

Full Income Statement

Balance Sheet

The company has 30.57 million in cash and 26.99 million in debt, giving a net cash position of 3.58 million.

Cash & Cash Equivalents	30.57M
Total Debt	26.99M
Net Cash	3.58M
Net Cash Per Share	n/a
Equity (Book Value)	-6.26M
Book Value Per Share	-0.22
Working Capital	50.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.12M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 93.12%, with operating and profit margins of -12.02% and -17.89%.

Gross Margin	93.12%
Operating Margin	-12.02%
Pretax Margin	-16.95%
Profit Margin	-17.89%
EBITDA Margin	-11.15%
EBIT Margin	-12.02%
FCF Margin	n/a

Dividends & Yields

TSX:FRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.25%
Shareholder Yield	-1.25%
Earnings Yield	-2.68%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333

Scores

TSX:FRX has an Altman Z-Score of -2.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.94
Piotroski F-Score	1